Financials Alkaloid AD Skopje

Equities

ALK

MKALKA101011

Pharmaceuticals

End-of-day quote MACEDONIAN S.E.
- MKD - Intraday chart for Alkaloid AD Skopje

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 9,783 11,103 12,132 12,794 14,289 16,513
EBITDA 1 1,411 1,586 1,889 1,986 2,207 2,506
EBIT 1 1,044 1,176 1,447 1,468 1,649 1,908
Operating Margin 10.67% 10.59% 11.92% 11.48% 11.54% 11.55%
Earnings before Tax (EBT) 1 968.8 1,188 1,328 1,457 1,644 1,786
Net income 1 862.4 1,015 1,168 1,302 1,463 1,577
Net margin 8.82% 9.14% 9.62% 10.18% 10.24% 9.55%
EPS 2 608.8 717.5 828.7 926.4 1,041 1,122
Free Cash Flow 1 674.8 248.1 -151.3 533.4 93.91 324.1
FCF margin 6.9% 2.23% -1.25% 4.17% 0.66% 1.96%
FCF Conversion (EBITDA) 47.82% 15.65% - 26.86% 4.26% 12.93%
FCF Conversion (Net income) 78.24% 24.44% - 40.96% 6.42% 20.55%
Dividend per Share - - - - - -
Announcement Date 8/27/19 4/6/20 4/5/21 10/31/22 4/3/23 4/1/24
1MKD in Million2MKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 154 422 905 960 1,202 1,402
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.1094 x 0.2662 x 0.4791 x 0.4833 x 0.5449 x 0.5593 x
Free Cash Flow 1 675 248 -151 533 93.9 324
ROE (net income / shareholders' equity) 9.47% 10.5% 11% 11.5% 12.1% 12%
ROA (Net income/ Total Assets) 5.6% 5.84% 6.32% 5.81% 6.16% 6.35%
Assets 1 15,388 17,398 18,469 22,399 23,760 24,825
Book Value Per Share 2 6,596 7,303 7,742 8,292 8,899 9,812
Cash Flow per Share 2 306.0 254.0 238.0 353.0 204.0 333.0
Capex 1 866 871 1,447 1,211 1,222 1,324
Capex / Sales 8.85% 7.84% 11.93% 9.46% 8.55% 8.02%
Announcement Date 8/27/19 4/6/20 4/5/21 10/31/22 4/3/23 4/1/24
1MKD in Million2MKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ALK Stock
  4. Financials Alkaloid AD Skopje